These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pharmacologic modulation of human cerebral activity: contribution of functional neuroimaging. Chollet F Neuroimaging Clin N Am; 2001 May; 11(2):375-80, x. PubMed ID: 11489746 [TBL] [Abstract][Full Text] [Related]
45. Experimental Models on Effects of Psychostimulants. Kõks S Int Rev Neurobiol; 2015; 120():107-29. PubMed ID: 26070755 [TBL] [Abstract][Full Text] [Related]
46. Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging. Strickland TL; Miller BL; Kowell A; Stein R Neuropsychol Rev; 1998 Mar; 8(1):1-9. PubMed ID: 9585919 [TBL] [Abstract][Full Text] [Related]
47. Correlation of behavioral and EEG effects during interaction studies with secobarbital and psychomotor stimulants. Killam KF; Slikker W; Brocco MJ; Gehrmann JE Proc West Pharmacol Soc; 1976; 19():432-4. PubMed ID: 11504 [No Abstract] [Full Text] [Related]
48. Neuroimaging and neurochemistry of autism. Chugani DC Pediatr Clin North Am; 2012 Feb; 59(1):63-73, x. PubMed ID: 22284793 [TBL] [Abstract][Full Text] [Related]
49. Presynaptic dopamine modulation by stimulant self-administration. Espana RA; Jones SR Front Biosci (Schol Ed); 2013 Jan; 5(1):261-76. PubMed ID: 23277050 [TBL] [Abstract][Full Text] [Related]
50. PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations. Gould RW; Duke AN; Nader MA Neuropharmacology; 2014 Sep; 84():138-51. PubMed ID: 23458573 [TBL] [Abstract][Full Text] [Related]
51. Addiction. Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627 [TBL] [Abstract][Full Text] [Related]
52. Neurotoxicants and central catecholamine systems. Mailman RB; Lewis MH Neurotoxicology; 1987; 8(1):123-39. PubMed ID: 3031560 [TBL] [Abstract][Full Text] [Related]
53. Applications of microdialysis methodology in nonhuman primates: practice and rationale. Bradberry CW Crit Rev Neurobiol; 2000; 14(2):143-63. PubMed ID: 11513243 [TBL] [Abstract][Full Text] [Related]
54. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. Volkow ND; Wang GJ; Ma Y; Fowler JS; Zhu W; Maynard L; Telang F; Vaska P; Ding YS; Wong C; Swanson JM J Neurosci; 2003 Dec; 23(36):11461-8. PubMed ID: 14673011 [TBL] [Abstract][Full Text] [Related]
55. An apparatus and behavioral training protocol to conduct positron emission tomography (PET) neuroimaging in conscious rhesus monkeys. Howell LL; Hoffman JM; Votaw JR; Landrum AM; Jordan JF J Neurosci Methods; 2001 Apr; 106(2):161-9. PubMed ID: 11325436 [TBL] [Abstract][Full Text] [Related]
56. Recent advances in the biology of addiction. Hemby SE Curr Psychiatry Rep; 1999 Dec; 1(2):159-65. PubMed ID: 11122919 [TBL] [Abstract][Full Text] [Related]
57. Neuroimaging and drug taking in primates. Murnane KS; Howell LL Psychopharmacology (Berl); 2011 Jul; 216(2):153-71. PubMed ID: 21360099 [TBL] [Abstract][Full Text] [Related]
58. Self-administration of stimulants and serotonergic systems. Roberts DS NIDA Res Monogr; 1992; 119():136-40. PubMed ID: 1359416 [No Abstract] [Full Text] [Related]
59. In vivo analysis of the role of dopamine in stimulant and opiate self-administration. Gratton A J Psychiatry Neurosci; 1996 Jul; 21(4):264-79. PubMed ID: 8754596 [TBL] [Abstract][Full Text] [Related]
60. The reinforcing and rate effects of intracranial dopamine administration. Dworkin SI; Goeders NE; Smith JE NIDA Res Monogr; 1986; 67():242-8. PubMed ID: 3092072 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]